Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Amgen
(NQ:
AMGN
)
338.45
-7.01 (-2.03%)
Streaming Delayed Price
Updated: 1:51 PM EST, Dec 1, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Amgen
< Previous
1
2
...
30
31
32
33
34
35
36
37
38
...
61
62
Next >
Treasury Yields Spiking As Market Looks Ahead To Jobs Data, Raising Valuation Concerns
↗
July 06, 2023
(Thursday market open) Things are heating up, and we’re not just talking about the July weather. A week from the start of Q2 earnings season, Wall Street is on tenterhooks awaiting tomorrow’s crucial...
Via
Benzinga
3 Biotech Stocks That AI Predicts Will Deliver Triple-Digit Returns in 2025
↗
July 05, 2023
In researching this article, we used AI to help make predictions for potential triple-digit return biotech stocks by 2025
Via
InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
↗
June 30, 2023
Via
Benzinga
15 Stocks Up, 15 Stocks Down: A Look At The Dow Jones Industrial Average Halfway Through 2023
↗
June 30, 2023
The stock market rebounded in 2023 with top indexes trading higher after 2022, which saw market declines.
Via
Benzinga
How Is The Market Feeling About Amgen?
↗
June 28, 2023
Via
Benzinga
7 Analysts Have This to Say About Amgen
↗
June 26, 2023
Via
Benzinga
Amgen Inc. Dividend Stock Analysis
↗
June 30, 2023
The company has paid a cash dividend to shareholders every year since 2011 and has increased its dividend payments for 13 consecutive years.
Via
Talk Markets
10 Health Care Stocks Whale Activity In Today's Session
↗
June 29, 2023
Via
Benzinga
Amgen Out, Rio Tinto In As Morgan Stanley Shuffles Dividend Deck
↗
June 29, 2023
Via
Benzinga
What Will Amgen Buy Next?
↗
June 29, 2023
The biotech could pursue these two budget-friendly targets.
Via
The Motley Fool
5 High-Yielding Dividend Stocks That Are Bargain Buys
↗
June 29, 2023
This is a good time for investors to load up on healthcare companies.
Via
The Motley Fool
A Look Into Amgen Inc's Price Over Earnings
↗
June 26, 2023
Via
Benzinga
If You Invested $1000 In This Stock 15 Years Ago, You Would Have $4,900 Today
↗
June 21, 2023
Via
Benzinga
Amgen's Debt Overview
↗
June 20, 2023
Via
Benzinga
5 Top Dividend Stocks to Buy in July 2023
↗
June 29, 2023
All 5 of these dividends stocks appear undervalued.
Via
The Motley Fool
Activision Blizzard Shares up 1.83% Amid Regulators' Blunders
June 27, 2023
Shares of Microsoft Corp. (NASDAQ: MSFT) declined 1.92% on June 26, more than the broader market, while Activision Blizzard Inc. (NASDAQ: ATVI) rose 1.83%. The S&P 500 declined 0.41% in the session.
Via
MarketBeat
Topics
Stocks
Next-Gen Weight-Loss Drugs Set To Up The Game From Ozempic And Mounjaro: WSJ
↗
June 27, 2023
Via
Benzinga
Why Viking Therapeutics Stock Is Crashing Today
↗
June 26, 2023
Investors seem concerned about the company's competitive positioning in weight loss.
Via
The Motley Fool
Why Amgen Stock Slumped on Monday
↗
June 26, 2023
Already under fire on the regulatory front, the company is hit with a price-target cut.
Via
The Motley Fool
Russian Insurrection Crushed: 5 Stocks That Continue To Have Exposure To The Country
↗
June 25, 2023
Via
Benzinga
4 Stocks That Can Turn $100,000 Into $500,000 by the Time You Retire
↗
June 24, 2023
Buy 'em and then just get out of the way. Time and these companies' long-term strength will take care of the rest.
Via
The Motley Fool
Moderating Inflation, a Tasty IPO, Bull Market Talk, and More
↗
June 22, 2023
We've also got two stocks worth watching: Chevron and Burford Capital.
Via
The Motley Fool
Alleged Industrial Espionage Makes an Interesting Story
↗
June 21, 2023
We also chat about Vertex Pharmaceuticals and its role at the center of cystic fibrosis treatment.
Via
The Motley Fool
How to Retire Rich: Biotech Stocks Edition
↗
June 18, 2023
Thanks to its enormous and practically permanent relevancies, the biotech sector offers a great avenue for retirement planning stocks.
Via
InvestorPlace
Eli Lilly Just Lent Its Big Pharma Cachet To Verve's Nascent Gene-Editing Program For $60 Million
↗
June 15, 2023
Eli Lilly inked a deal worth $60 million to get in on a gene-editing drug for elevated lipoprotein A.
Via
Investor's Business Daily
5 Stocks to Buy With Explosive 500% Potential
↗
June 12, 2023
Take advantage of a bullish change in investor sentiment with these five stocks to buy for 500% upside potential.
Via
InvestorPlace
Is the Biotech Industry (IBB) Poised For A Major Breakout?
June 12, 2023
The current consolidation in the IBB signals a potential breakout might be looming as key moving averages have converged within a contracted price range.
Via
MarketBeat
Topics
ETFs
Is AbbVie or Amgen the Better Bargain Buy Right Now?
↗
June 08, 2023
These elite drugmakers are both working through a number of headwinds.
Via
The Motley Fool
ASCO 2023 – Claudin 6 Makes A Splash In Ovarian Cancer
↗
June 08, 2023
This year’s 2023 American Society of Clinical Oncology Annual Meeting (ASCO 2023) provided a surprising amount of clinical data relevant to biopharma investors.
Via
Benzinga
Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 3% Dividend Yields
↗
June 08, 2023
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...
Via
Benzinga
< Previous
1
2
...
30
31
32
33
34
35
36
37
38
...
61
62
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.